To ask the Secretary of State for Health, what estimate his Department has made of the rebate from the PPRS scheme (a) in cash terms and (b) as a proportion of overall medicines spend in 2015-16 and 2016-17; and what earlier estimate his Department has made for that period.
The Pharmaceutical Price Regulation Scheme (PPRS) payment estimate for the United Kingdom in 2015-16 is £995 million. The increase in PPRS payment estimates has been taken into account as part of the NHS Mandate allocation for 2015-16. The latest estimate of overall health service medicines spend (branded and generic) for England in 2013-14 is £13,339 million. This is the latest year for which data is available. As this is for a different period and is England only, it would be misleading to express the anticipated PPRS Payments for 2015-16 as a proportion of that spend.
We do not intend to publish an estimate of cash payments for 2016-17, as it is not possible to make a reliable estimate looking this far ahead. The payment percentages for 2015 and 2016 are currently estimated to be 10.36% and 15.0% of eligible branded spend respectively, however 2016 will be adjusted on the basis of final outturn in 2014, 2015, and is therefore indicative.